Drs. Ananta Addala, Danny Chou, Anna Gloyn and Rayhan Lal spoke to The SugarScience on flexing innovations in genetics, insulin bioengineering, and diabetes technology to advance health equity in diabetes diagnosis and management.
Drs. Ananta Addala, Danny Chou, Anna Gloyn and Rayhan Lal spoke to The SugarScience on flexing innovations in genetics, insulin bioengineering, and diabetes technology to advance health equity in diabetes diagnosis and management.